Boosters for adeno-associated virus (AAV) vector (r)evolution

Cytotherapy. 2023 Mar;25(3):254-260. doi: 10.1016/j.jcyt.2022.07.005. Epub 2022 Aug 20.


Adeno-associated virus (AAV) is one of the most exciting and most versatile templates for engineering of gene-delivery vectors for use in human gene therapy, owing to the existence of numerous naturally occurring capsid variants and their amenability to directed molecular evolution. As a result, the field has witnessed an explosion of novel "designer" AAV capsids and ensuing vectors over the last two decades, which have been isolated from comprehensive capsid libraries generated through technologies such as DNA shuffling or peptide display, and stratified under stringent positive and/or negative selection pressures. Here, we briefly highlight a panel of recent, innovative and transformative methodologies that we consider to have exceptional potential to advance directed AAV capsid evolution and to thereby accelerate AAV vector revolution. These avenues comprise original technologies for (i) barcoding and high-throughput screening of individual AAV variants or entire capsid libraries, (ii) selection of transduction-competent AAV vectors on the DNA level, (iii) enrichment of expression-competent AAV variants on the RNA level, as well as (iv) high-resolution stratification of focused AAV capsid libraries on the single-cell level. Together with other emerging AAV engineering stratagems, such as rational design or machine learning, these pioneering techniques promise to provide an urgently needed booster for AAV (r)evolution.

Keywords: AAV; Adeno-associated virus; barcoding; molecular evolution; scRNA-seq; selection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Capsid
  • Capsid Proteins / chemistry
  • Capsid Proteins / genetics
  • Dependovirus* / genetics
  • Gene Transfer Techniques
  • Genetic Therapy* / methods
  • Genetic Vectors / genetics
  • Humans


  • Capsid Proteins